Crispr Therapeutics (Nasdaq: CRSP) stands at the forefront of gene-editing technology, aiming to develop revolutionary treatments for serious diseases.
The company recently achieved a significant milestone with the approval of Casgevy, the world’s first CRISPR-based therapy, which treats sickle...
You always remember your first…
I’m talking about investments, of course. What did you think I was referring to?
I bought my first stock in 1990. It was Harley-Davidson (NYSE: HOG). I bought 50 shares at $12. Three months later,...
You probably remember the old commercials featuring a bored Maytag repairman. In the ads, because Maytag appliances were so reliable, the repairman was often snoozing because he had nothing to do.
Today, Maytag is owned by Whirlpool (NYSE: WHR),...
Editor’s Note: I’ve always appreciated how Karim Rahemtulla and the whole team at Monument Traders Alliance avoid any bias or political agenda and focus on one thing only: delivering results for their readers.
Today, I’ve invited Karim to share...
Dell Technologies (NYSE: DELL), the household name in computers and IT infrastructure, has been on a wild market ride.
After hitting lows just under $35 in 2022, the stock surged dramatically to reach more than $175 in mid-2024 before...
The world was a lot different just four years ago.
The United States was about two months into Joe Biden’s presidency, public places like gyms and schools remained closed in some parts of the country due to COVID-19 restrictions,...
Delek Logistics Partners (NYSE: DKL) is a Tennessee-based master limited partnership with 850 miles of oil pipelines and other energy-related assets.
Its most recent distribution (partnerships’ dividends are called distributions) in February was $1.105 per share. Annualized, that comes...
A friend who is a bit younger than me told me that his financial advisor recommended selling his stocks in favor of bond funds because of the coming bear market. He asked me what I thought.
“That’s the dumbest...
Editor’s Note: Back in April 2024, despite Nvidia’s 500% surge in under a year and a half, Director of Trading Anthony Summers gave the stock a “Slightly Undervalued” rating right here in his Value Meter column.
Some might’ve been...
For a fleeting moment in college, I thought I might be a psych major.
That didn’t end up happening, but it turned out that in my career, I’ve “majored” in market psychology.
As Liam Neeson might say, I have “a...
